Company / Free Cash Flow per Share
Fulgent Genetics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4.03
FY2025
5-year range
-$4.03 / $17.49
FY2021-FY2025
Trend
-520.2%
vs FY2024
Sector context
#144 of 148
Health Care
What the data says
Free Cash Flow per Share changed -520% YoY in FY2025, a notable deviation from the 9-year average annual change of +546%.
Based on SEC 10-K filings.
-4.03 in FY2025.
Declined from $17.49 to $-4.03 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 148This company -$4.03 Sector average $5.04
▼
-179.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 520.2% year-over-year.
- Ranks #144 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.03 | -520.2% |
| FY2024 | -$0.65 | -103.7% |
| FY2023 | $17.49 | +399.9% |
| FY2022 | $3.50 | +2173.7% |
| FY2021 | $0.15 | -96.9% |
| FY2020 | $4.91 | +3077.6% |
| FY2019 | -$0.16 | -88.2% |
| FY2018 | -$0.09 | +1.0% |
| FY2017 | -$0.09 | +69.5% |
| FY2016 | -$0.29 | -11.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026